Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB023 Extension in Lupus Nephritis
NCT01930890Phase 2Terminated
- Sponsor
- Biogen
- Start
- Nov 2013
- Primary completion
- Jan 2016
- Modality
- Monoclonal Antibodies
- Countries
- 19
01
Overview
A Phase 2 trial of voralizumab in lupus nephritis (LN), sponsored by Biogen. Started Nov 2013; status: terminated.
02
Drugs
voralizumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01930890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01930890.